EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, ‘Filing A Gap’ In Regulations
The American Medical Association (AMA) is expected to issue the first code for psychedelic therapy reimbursement, following Tuesday's approval of a joint application submitted by MAPS PBC and COMPASS Pathways (NASDAQ: CMPS).
